The enhanced aromatase activity and high estrogen levels in patients with obesity can promote the excessive proliferation of breast tissue and inhibit cell apoptosis, which leads to the occurrence and progression of BC (24, 39). The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.